|
|
CTHRC1在器官纤维化中的研究进展
|
Abstract:
器官纤维化是慢性炎症性器官损伤引起的细胞异常修复，导致正常组织被含有过量细胞外基质的瘢痕组织所代替的病理过程。纤维化疾病可以累及几乎全身所有器官，器官纤维化疾病进展将导致器官功能障碍。流行病学调查发现，在发达国家，有45%的患者死于慢性纤维化疾病，全球纤维化疾病发病率和相关医疗负担正逐年升高。三螺旋重复胶原蛋白1 (CTHRC1)是一种细胞外基质糖蛋白，通常是表达在上皮–间质界面，广泛参与生长发育、损伤修复、器官纤维化、肿瘤侵袭和转移过程。转化生长因子β能与CTHRC1相互作用，通过激活成纤维细胞影响胶原表达和沉积，参与器官纤维化过程。本文就CTHRC1与器官纤维化中的关系进行综述。
Organ fibrosis is a pathological process in which chronic inflammatory organ injury causes abnor-mal cellular repair, resulting in the replacement of normal tissue with scar tissue containing excess extracellular matrix (ECM). Fibrotic disease can involve almost all organs throughout the body, and progression of organ fibrotic disease will lead to organ dysfunction. Epidemiological surveys have found that 45% of patients in developed countries die from chronic fibrotic disease, and the global incidence of fibrotic disease and associated medical burden is increasing year by year. Collagen tri-ple helix repeat containing-1 (CTHRC1) is an extracellular matrix glycoprotein that is normally ex-pressed at the epithelial-mesenchymal interface and is widely involved in growth and development, injury repair, organ fibrosis, tumor invasion and metastasis processes. Transforming growth factor β (TGF-β) can interact with CTHRC1 to affect collagen expression and deposition through activation of fibroblasts and participate in the organ fibrosis process. This article provides a review of the rela-tionship between CTHRC1 and organ fibrosis.
| [1] | Mei, D., Zhu, Y., Zhang, L., et al. (2020) The Role of CTHRC1 in Regulation of Multiple Signaling and Tumor Progres-sion and Metastasis. Mediators of Inflammation, 2020, Article ID: 9578701. https://doi.org/10.1155/2020/9578701 |
| [2] | Pyagay, P., et al. (2005) Collagen Triple Helix Repeat Containing-1, a Novel Secreted Protein in Injured and Diseased Arteries, Inhibits Collagen Expression and Promotes Cell Migration. Circulation Research, 96, 261-268.
https://doi.org/10.1161/01.RES.0000154262.07264.12 |
| [3] | Stohn, J.P., Perreault, N.G., Wang, Q., et al. (2012) CTHRC1, a Novel Circulating Hormone Regulating Metabolism. PLOS ONE, 10, e47142. https://doi.org/10.1371/journal.pone.0047142 |
| [4] | Qin, S., Zheng, J.H., Xia, Z.H., et al. (2019) CTHRC1 Pro-motes Wound Repair by Increasing M2 Macrophages via Regulating the TGF-β and Notch Pathways. Biomedicine & Pharmacotherapy, 2019, Article ID: 108594.
https://doi.org/10.1016/j.biopha.2019.01.055 |
| [5] | Han, Y., You, X., Xing, W., et al. (2018) Paracrine and Endo-crine Actions of Bone—The Functions of Secretory Proteins from Osteoblasts, Osteocytes, and Osteoclasts. Bone Re-search, 6, 16. https://doi.org/10.1038/s41413-018-0019-6 |
| [6] | Durmus, T., LeClair, R.J., Park, K.S., et al. (2006) Expression Analysis of the Novel Gene Collagen Triple Helix Repeat Containing-1 (CTHRC1). Gene Expression Pat-terns, 6, 935-940. https://doi.org/10.1016/j.modgep.2006.03.008 |
| [7] | Pérez-Mies, B., Caniego-Casas, T., Bardi, T., et al. (2022) Progression to Lung Fibrosis in Severe COVID-19 Patients: A Morphological and Transcriptomic Study in Postmortem Samples. Frontiers in Medicine (Lausanne), 2022, Article ID: 976759. https://doi.org/10.3389/fmed.2022.976759 |
| [8] | Binks, A.P., Beyer, M., Miller, R., et al. (2017) CTHRC1 Lowers Pulmonary Collagen Associated with Bleomycin- Induced Fibrosis and Protects Lung Function. Physiological Reports, 5, e13115. https://doi.org/10.14814/phy2.13115 |
| [9] | Shah, H., Hacker, A., Langburt, D., et al. (1970) Myocardial Infarction Induces Cardiac Fibroblast Transformation within Injured and Noninjured Regions of the Mouse Heart. Jour-nal of Proteome Research, 5, 2867-2881.
https://doi.org/10.1021/acs.jproteome.1c00098 |
| [10] | Ruiz-Villalba, A., Romero, J.P., Hernández, S.C., et al. (1970) Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts after Myocardial Infarction. Circulation, 19, 1831-1847. https://doi.org/10.1161/CIRCULATIONAHA.119.044557 |
| [11] | Li, J., Wang, Y., Ma, M., et al. (2019) Autocrine CTHRC1 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis by Activating TGF-β Signaling. EBioMedicine, 40, 43-55. https://doi.org/10.1016/j.ebiom.2019.01.009 |
| [12] | Li, Y.K., Li, Y.M., Li, Y., et al. (2019) CTHRC1 Expres-sion in Primary Biliary Cholangitis. Journal of Digestive Diseases, 7, 371-376. https://doi.org/10.1111/1751-2980.12791 |
| [13] | Bian, Z., Miao, Q., Zhong, W., et al. (2015) Treatment of Cholestat-ic Fibrosis by Altering Gene Expression of CTHRC1: Implications for Autoimmune and Non-Autoimmune Liver Dis-ease. Journal of Autoimmunity, 63, 76-87.
https://doi.org/10.1016/j.jaut.2015.07.010 |
| [14] | Fabris, L. and Strazzabosco, M. (2011) Epithelial-Mesenchymal In-teractions in Biliary Diseases. Seminars in Liver Disease, 1, 11-32. https://doi.org/10.1055/s-0031-1272832 |
| [15] | Kisseleva, T., Uchinami, H., Feirt, N., et al. (2006) Bone Mar-row-Derived Fibrocytes Participate in Pathogenesis of Liver Fibrosis. Journal of Hepatology, 3, 429-438. https://doi.org/10.1016/j.jhep.2006.04.014 |
| [16] | Zhao, M.J., Chen, S.Y., Qu, X.Y., et al. (2018) Increased CTHRC1 Activates Normal Fibroblasts and Suppresses Keloid Fibroblasts by Inhibiting TGF-β/Smad Signal Pathway and Modulating YAP Subcellular Location. Current Medical Science, 5, 894-902. https://doi.org/10.1007/s11596-018-1959-1 |
| [17] | LeClair, R. and Lindner, V. (2007) The Role of Collagen Triple Helix Repeat Containing 1 in Injured Arteries, Collagen Expression, and Transforming Growth Factor Beta Signaling. Trends in Cardiovascular Medicine, 6, 202-205.
https://doi.org/10.1016/j.tcm.2007.05.004 |
| [18] | 陈耿, 周毅, 冯凯. 移植物胆管病发病机制与防治策略的研究进展[J]. 中华普通外科杂志, 2019(8): 736-738. |
| [19] | Buis, C.I., Hoekstra, H., Verdonk, R.C., et al. (2006) Causes and Consequences of Ischemic-Type Biliary Lesions after Liver Transplantation. Journal of Hepato-Biliary-Pancreatic Sci-ences, 6, 517-524.
https://doi.org/10.1007/s00534-005-1080-2 |
| [20] | Carpentier, R., Su？er, R.E., Van Hul, N., et al. (2011) Embryonic Ductal Plate Cells Give Rise to Cholangiocytes, Periportal Hepatocytes, and Adult Liver Progenitor Cells. Gastroenter-ology, 4, 1432-1438.
https://doi.org/10.1053/j.gastro.2011.06.049 |
| [21] | Haruna, Y., Saito, K., Spaulding, S., et al. (1996) Identification of Bipotential Progenitor Cells in Human Liver Development. Hepatology, 3, 476-481. https://doi.org/10.1002/hep.510230312 |
| [22] | Omenetti, A., Yang, L., Li, Y.X., et al. (2007) Hedgehog-Mediated Mesenchymal-Epithelial Interactions Modulate Hepatic Response to Bile Duct Ligation. Laboratory Investigation, 5, 499-514.
https://doi.org/10.1038/labinvest.3700537 |
| [23] | Liu, X., Li, J., Xiong, J., et al. (2012) Notch-Dependent Expression of Epithelial-Mesenchymal Transition Markers in Cholangiocytes after Liver Transplantation. Hepatology Research, 10, 1024-1038.
https://doi.org/10.1111/j.1872-034X.2012.01011.x |
| [24] | Clapéron, A., Guedj, N., Mergey, M., et al. (2012) Loss of EBP50 Stimulates EGFR Activity to Induce EMT Phenotypic Features in Biliary Cancer Cells. Oncogene, 11, 1376-1388. https://doi.org/10.1038/onc.2011.334 |
| [25] | Geng, Z.M., Yao, Y.M., Liu, Q.G., et al. (2005) Mechanism of Benign Biliary Stricture: A Morphological and Immunohistochemical Study. World Journal of Gastroenterology, 2, 293-295. https://doi.org/10.3748/wjg.v11.i2.293 |
| [26] | Popov, Y., Patsenker, E., Stickel, F., et al. (2008) Integrin alphavbeta6 Is a Marker of the Progression of Biliary and Portal Liver Fibrosis and a Novel Target for Antifibrotic Therapies. Journal of Hepatology, 3, 453-464.
https://doi.org/10.1016/j.jhep.2007.11.021 |
| [27] | Inagaki, Y. and Okazaki, I. (2007) Emerging Insights into Trans-forming Growth Factor Beta Smad Signal in Hepatic Fibrogenesis. Gut, 2, 284-292. https://doi.org/10.1136/gut.2005.088690 |
| [28] | 赵一霖, 王皓洁, 詹江华. 胆道闭锁TGFβ1诱导EMT相关通路研究进展[J]. 临床小儿外科杂志, 2021, 20(12): 1189-1193. |
